1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Intracranial bleeding complications
Type of Intracranial Bleeding Asymptomatic (%) Symptomatic (%) Total (%) PH1 6 (4.2) 1 (0.7) 7 (4.9) PH2 5 (3.5) 1 (0.7) 6 (4.2) RIH 1 (0.7) 0 (0) 1 (0.7) IVH 5 (3.5) 1 (0.7) 6 (4.2) SAH 6 (4.2) 5 (3.5) 11 (7.6)
Note:—Total number of subjects with symptomatic cerebral hemorrhage is less than the sum of individual subtype rows because some subjects had more than 1 radiologic subtype of intracranial hemorrhage. RIH indicates any intraparenchymal hemorrhage remote from the ischemic field; IVH, intraventricular hemorrhage.